US FDA approves Johnson & Johnson's drug for immune-mediated disorder
The US FDA has approved Johnson & Johnson’s drug to treat patients aged 12 years and older with an immune-mediated disorder Source link
Johnson & Johnson
Read More
Farewell, Don Draper: AI is coming for advertising
“Change is neither good nor bad. It simply is,” declares Donald Draper, the unflappable star of “Mad Men”, a television drama set in 1960s adland. Not all advertising executives share his sangfroid. Today, technology is changing the industry faster than at any time since Mr Draper’s era. The result is a reshaping of Madison Avenue…